Not all suicidality is the same: Subtypes may lead to better diagnostic formulationStudy explores the usability and feasibility of four subtypes of suicidality in emergency mental healthcare. Psychedelic drug MDMA faces questions as U.S. FDA considers approval for PTSDIn their assessment, FDA scientists said that patients who received MDMA and talk therapy showed ‘rapid, clinically meaningful, durable improvements in their PTSD symptoms.’ Are computer games helpful for managing ADHD or not? Studies show they can help cognitive memory, plus other advantages. Medical trainees are vaping a lot—and it appears to be connected with their mental health They may be doing it as a way to cope with mental health issues. Daily marijuana use outpaces daily drinking in the U.S. Alcohol is still more widely used, but 2022 was the first time this intensive level of marijuana use overtook daily and near-daily drinking. The startling side effects of loneliness Even though we are often constantly surrounded by co-workers, customers and patients, pharmacists can be particularily susceptible to loneliness. Updated Canadian guidelines for management of depression in adults Revised CANMAT guidelines outline patient assessment, selection of evidence-based treatments, prevention of recurrence and strategies for managing inadequate response. Why effective suicide-risk assessment might look different for Black children ‘If the child is not telling you, they probably don’t feel comfortable telling you.’ We looked at genetic clues to depression in more than 14,000 people. What we found may surprise you These psychiatry researchers think contrasting ‘reactive’ depression with ‘endogenous depression is far too simple. Antipsychotics associated with a wide range of adverse outcomes in dementia Risks of a broad range of adverse outcomes need to be considered before prescribing antipsychotic drugs for people with dementia. First Previous 5 6 7 8 9 Next Last
